Literatur
Nach Informationen von Bayer Pharma
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
red Nierenzellkarzinom: Erst Sorafenib, dann Sunitinib. Info Onkol. 17, 63 (2014). https://doi.org/10.1007/s15004-014-1005-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15004-014-1005-9